Highland Capital Management (Tennessee)’s Charles River Laboratories CRL Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,869	Closed	-$975K	–	312
2019 Q2	$975K	Buy	+6,869	New	+$932K	0.07%	217
2019 Q1	–	Sell	-11,006	Closed	-$1.25M	–	325
2018 Q4	$1.25M	Buy	+11,006	New	+$1.38M	0.11%	183
2017 Q2	–	Sell	-7,204	Closed	-$648K	–	361
2017 Q1	$648K	Sell	7,204 -1,792	-20%	-$152K	0.05%	235
2016 Q4	$685K	Sell	8,996 -2,705	-23%	-$205K	0.06%	237
2016 Q3	$975K	Buy	11,701 +133	+1%	+$11.1K	0.08%	222
2016 Q2	$954K	Buy	+11,568	New	+$953K	0.08%	211

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Highland Capital Management (Tennessee)'s CRL Position: Q3 2019 in Review

Highland Capital Management (Tennessee) sold out of Charles River Laboratories (CRL) in Q3 2019, closing a stake of 6,869 shares — an estimated $975K sold.

Highland Capital Management (Tennessee) first reported a position in CRL in Q2 2016 and held it in 6 quarters. The position peaked at $1.25M in Q4 2018. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

Highland Capital Management (Tennessee) reported no remaining Charles River Laboratories position as of Q3 2019 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 6,869 Charles River Laboratories shares in Q3 2019, an estimated $975K.
Highland Capital Management (Tennessee) first reported a position in Charles River Laboratories in Q2 2016 and held it in 6 quarters.
Highland Capital Management (Tennessee)'s Charles River Laboratories position peaked at $1.25M in Q4 2018.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q3 2019, filed 20 Nov 2019.